Latest Lymphoma News
Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCL
Maintenance therapy with rituximab yielded better survival outcomes for older patients with…
Year in Review: Follicular Lymphoma
Studies demonstrating high response rates and manageable safety profiles, along with FDA…
FDA Panel: Tolerating Approval Outliers Would Set ‘Dangerous Precedent’
An unprecedented wait for final FDA approval will drag on for two…
Lymphoma Drug Copanlisib to Be Pulled From U.S. Market
Bayer announced plans to pull its follicular lymphoma drug copanlisib (Aliqopa) from…
